BIOCRYST PHARMACEUTICALS's ticker is and the CUSIP is 09058V903. A total of 4 filers reported holding BIOCRYST PHARMACEUTICALS in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,819,000 | – | 550,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 24,600 | $241,000 | 0.00% |
| Citadel Advisors | 32,400 | $317,000 | 0.00% |